Combined Factor VIII and IX Inhibitors in a Girl

Summary

A case is described of a 5 year old child, who for several years presented a moderate haemorrhagic symptomatology. Tests have shown a deficiency due to clotting inhibitors; in the present case the inhibitors act against factors VIII and IX.

• References

• 1 Egeberg O. Acquired circulating anticoagulant in Classical Hemophilia. Scand. J. clin. Lab. Invest 13: 535 1961;
• 2 Goudemand M, Foucaut M, Hutin A, Parquet-Gernes A. Les anticoagulants circulants antifacteur VIII au cours de l’hemophilie A. Nature et mecanisme d’action. Nouv. Rev. franç. Hémat 3: 703 1963;
• 3 Beck E, Bachmann F, Müller J, Duckert F. Formation of an Inhibitor against Factor VIII as a postoperative complication in a severe case of Hemophilia A. Thrombos. Diathes. haemorrh. (Stuttg.) VII: 27 1962;
• 4 Biggs R, Bidwell E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Brit. J. Haemat 5: 379 1959;
• 5 Margolius A, Jackson D. P, Ratnojf O. D. Circulating anticoagulant: a study of 40 cases and review of the literature. Medicine 40: 145 1961;
• 6 Kleimans M. Pseudohemofilia por anticoagulante Rev. Soc. argent. Hemat 7: 14 1961;
• 7 Sise H. S, Gauthier J, Desforges J, Becker R. Spontaneous Circulating Anticoagulant (Anti-factor VIII). Case Report and Review of the Literature. Amer. J. Med 32: 964 1962;
• 8 Lee M. L, Raccuglia G. Acquired Inhibitor of Blood Coagulation. Ann. intern. Med 56: 946 1962;
• 9 Nussey A. M, Dawson D. W. Haemophilia-like Disease Due to an Auto-Antibody. Brit, med. J 17: 1077 1957;
• 10 Ehrenworth L. Spontaneously occuring anticoagulant against Antihemophilic Globulin in a Previously Normal Subject. Amer. J. Med 34: 272 1963;
• 11 Pinkerton P. H, Dagg J. H, Taylor F. A Circulating anticoagulant inhibiting antihemophilic globulin. J. clin. Path 18: 334 1965;
• 12 Biggs R, Macfariane G. R. Human Blood Coagulation and its disorders. Blackwell Scientific Publications; Oxford: 1962
• 13 Quick A. J. Fisiología y Patología de la Hemostasia. Editorial El Ateneo; Buenos Aires: 1952
• 14 Quick A. J. J, Favre Gilly E. The prothrombin consumption test: its clinical and theoretic implications. Blood 4: 1281 1949;
• 15 Proctor R. R, Rapaport S. I. The partial thromboplastin time with Kaolin. Amer. J. clin. Path 30: 212 1961;
• 16 vonK aulla K. N, Schultz R. L. Methods for the evaluation of human fibrinolysis. Amer. J. clin. Path 29: 104 1958;
• 17 Nossei H. L. The Contact Phase of Blood Coagulation. Blackwell Scientific Publications; Oxford: 1964
• 18 Hougie G. Fundamentals of Blood Coagulation in Clinical Medicine. McGraw-Hill; New York: 1963
• 19 Stefanini M, Dameshek W. Enfermedades Hemorrágicas. Ed. Científico-Médica; Barcelona: 1957
• 20 Marchai G, Leroux M. E, Samama M. Atlas de Thrombodynamographie. APEI; Paris: 1962
• 21 Koller F, Loeliger A, Duckert F. “Experiments on a new clotting factor.” Acta haemat. (Basel) 6: 1 1951;
• 22 Grabar P, Burtin P. Immuno-electrophoretic analysis. Elsevier Pub. Co.; Amsterdam: 1964
• 23 Reussi G, Altman R, Rouvier J. Raro defecto hemofílico en una nina. Rev. Asoc. méd. argent 75: 470 1964;
• 24 Eliakim M. Antihaemophilic Globulin and Plasma Thromboplastin Component Deficiences Associated with a Qualitative Platelet Disturbance. Acta haemat. (Basel) 28: 61 1962;
• 25 Robertson J. H, Trueman R. G. Combined Hemophilia and Christmas Disease. Blood 24: 281 1964;
• 26 Lewis J. H, Ferguson J. H, Arenas T. Hemorrhagic disease with circulating inhibitors of blood clotting: Anti-AHF and anti-PTC in eight cases. Blood 11: 846 1956;
• 27 Biggs R, Denson K. W. E. The mode of action of a coagulation inhibitor in the blood of two patients with Disseminated Lupus Erythematosus (DLE). Brit. J. Haemat 10: 198 1964;